Mutations in SUFU predispose to medulloblastoma - PubMed (original) (raw)
doi: 10.1038/ng916. Epub 2002 Jun 17.
Ling Liu, Corey Raffel, Chi-chung Hui, Todd G Mainprize, Xiaoyun Zhang, Ron Agatep, Sharon Chiappa, Luzhang Gao, Anja Lowrance, Aihau Hao, Alisa M Goldstein, Theodora Stavrou, Stephen W Scherer, Wieslaw T Dura, Brandon Wainwright, Jeremy A Squire, James T Rutka, David Hogg
Affiliations
- PMID: 12068298
- DOI: 10.1038/ng916
Mutations in SUFU predispose to medulloblastoma
Michael D Taylor et al. Nat Genet. 2002 Jul.
Abstract
The sonic hedgehog (SHH) signaling pathway directs the embryonic development of diverse organisms and is disrupted in a variety of malignancies. Pathway activation is triggered by binding of hedgehog proteins to the multipass Patched-1 (PTCH) receptor, which in the absence of hedgehog suppresses the activity of the seven-pass membrane protein Smoothened (SMOH). De-repression of SMOH culminates in the activation of one or more of the GLI transcription factors that regulate the transcription of downstream targets. Individuals with germline mutations of the SHH receptor gene PTCH are at high risk of developmental anomalies and of basal-cell carcinomas, medulloblastomas and other cancers (a pattern consistent with nevoid basal-cell carcinoma syndrome, NBCCS). In keeping with the role of PTCH as a tumor-suppressor gene, somatic mutations of this gene occur in sporadic basal-cell carcinomas and medulloblastomas. We report here that a subset of children with medulloblastoma carry germline and somatic mutations in SUFU (encoding the human suppressor of fused) of the SHH pathway, accompanied by loss of heterozygosity of the wildtype allele. Several of these mutations encode truncated proteins that are unable to export the GLI transcription factor from nucleus to cytoplasm, resulting in the activation of SHH signaling. SUFU is a newly identified tumor-suppressor gene that predisposes individuals to medulloblastoma by modulating the SHH signaling pathway through a newly identified mechanism.
Similar articles
- Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
Vorechovský I, Tingby O, Hartman M, Strömberg B, Nister M, Collins VP, Toftgård R. Vorechovský I, et al. Oncogene. 1997 Jul 17;15(3):361-6. doi: 10.1038/sj.onc.1201340. Oncogene. 1997. PMID: 9233770 - Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
Vortmeyer AO, Stavrou T, Selby D, Li G, Weil RJ, Park WS, Moon YW, Chandra R, Goldstein AM, Zhuang Z. Vortmeyer AO, et al. Cancer. 1999 Jun 15;85(12):2662-7. Cancer. 1999. PMID: 10375116 - Insight into the pathogenesis of sporadic basal cell carcinoma.
Holíková Z, Massi D, Lotti T, Hercogová J. Holíková Z, et al. Int J Dermatol. 2004 Dec;43(12):865-9. doi: 10.1111/j.1365-4632.2004.02319.x. Int J Dermatol. 2004. PMID: 15569004 Review. - Role and regulation of human tumor suppressor SUFU in Hedgehog signaling.
Cheng SY, Yue S. Cheng SY, et al. Adv Cancer Res. 2008;101:29-43. doi: 10.1016/S0065-230X(08)00402-8. Adv Cancer Res. 2008. PMID: 19055941 Review.
Cited by
- Hedgehog signaling pathway and ovarian cancer.
Chen Q, Gao G, Luo S. Chen Q, et al. Chin J Cancer Res. 2013 Jun;25(3):346-53. doi: 10.3978/j.issn.1000-9604.2013.06.04. Chin J Cancer Res. 2013. PMID: 23825912 Free PMC article. - Frequency of pathogenic germline variants in pediatric medulloblastoma survivors.
Rees D, Gianferante DM, Kim J, Stavrou T, Reaman G, Sapkota Y, Gramatges MM, Morton LM, Hudson MM, Armstrong GT, Freedman ND, Huang WY, Diver WR, Lori A, Luo W, Hicks BD, Liu J, Hutchinson AA, Goldstein AM, Mirabello L. Rees D, et al. Front Oncol. 2024 Aug 9;14:1441958. doi: 10.3389/fonc.2024.1441958. eCollection 2024. Front Oncol. 2024. PMID: 39184053 Free PMC article. - RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.
Zhao X, Ponomaryov T, Ornell KJ, Zhou P, Dabral SK, Pak E, Li W, Atwood SX, Whitson RJ, Chang AL, Li J, Oro AE, Chan JA, Kelleher JF, Segal RA. Zhao X, et al. Cancer Res. 2015 Sep 1;75(17):3623-35. doi: 10.1158/0008-5472.CAN-14-2999-T. Epub 2015 Jun 30. Cancer Res. 2015. PMID: 26130651 Free PMC article. - ABT-737 suppresses aberrant Hedgehog pathway and overcomes resistance to smoothened antagonists by blocking Gli.
Huang W, Liu H, Tan W, Wang J. Huang W, et al. Med Oncol. 2022 Sep 7;39(12):188. doi: 10.1007/s12032-022-01794-w. Med Oncol. 2022. PMID: 36071246 - Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol.
Wang F, Stappenbeck F, Matsui W, Parhami F. Wang F, et al. J Cell Biochem. 2017 Mar;118(3):499-509. doi: 10.1002/jcb.25668. Epub 2016 Sep 21. J Cell Biochem. 2017. PMID: 27490478 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous